KSC Equity Snapshot
019175 Weekly Equity Report
Shinpoong Pharmaceutical Co.,Ltd
What the company does
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is …
What the weekly tape is saying
019175 closed the latest completed week at 14,000 KRW. The 4-week return is -23.1% and the 12-week return is -16.2%. Trend Signal is inactive, Market Dynamics is -0.14. Setup signature: Risk-first tape with a 11/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 19,700 KRW
- Vs Trend Line
- -28.9%
- Fair Value
- 21,268 KRW
- Vs Fair Value
- -34.2%
- 52W High
- 55,000 KRW
- 52W Low
- 13,400 KRW
- Drawdown
- -74.5%
- Range Position
- 1.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 22
- 52W Active Breadth
- 42.3%
- Sector Scope
- KR Healthcare
- Sector Rank
- 43 of 63
- Sector Percentile
- 32.3%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 58 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 41 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.14
- 4W MD Change
- -132.2%
- Relative Strength
- -68.55
- 4W RS Change
- -14.3%
- Expectation
- Negative
- Probability
- 37.51%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 12.5K
- 13W Average
- 62.7K
- 52W Average
- 82.1K
- Vs 13W
- 0.2x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 17.1%
- 52W Volatility
- 12.5%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 9.7% / -6.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 805.3B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 14,000 KRW | -1.8% | 19,700 KRW | 21,268 KRW | -0.14 | -68.55 | 12.5K | Off |
| 5 Jun 2026 | 14,250 KRW | -10.9% | 20,134 KRW | 21,361 KRW | 0.03 | -69.10 | 27.0K | Off |
| 29 May 2026 | 16,000 KRW | -8.6% | 20,499 KRW | 21,449 KRW | 0.22 | -67.70 | 19.6K | Off |
| 22 May 2026 | 17,500 KRW | -3.8% | 20,819 KRW | 21,539 KRW | 0.34 | -62.79 | 29.4K | Off |
| 15 May 2026 | 18,200 KRW | -8.2% | 21,057 KRW | 21,619 KRW | 0.42 | -59.95 | 39.8K | Off |
| 8 May 2026 | 19,830 KRW | 4.4% | 21,217 KRW | 21,692 KRW | 0.56 | -56.67 | 29.5K | Off |
| 1 May 2026 | 19,000 KRW | -0.9% | 21,346 KRW | 21,759 KRW | -0.00 | -53.14 | 26.8K | Off |
| 24 Apr 2026 | 19,180 KRW | -21.6% | 21,549 KRW | 21,840 KRW | -0.54 | -52.08 | 98.0K | Off |
| 17 Apr 2026 | 24,450 KRW | 54.7% | 21,757 KRW | 21,914 KRW | -1.11 | -36.48 | 485.6K | Off |
| 10 Apr 2026 | 15,800 KRW | -0.1% | 21,755 KRW | 21,966 KRW | -1.79 | -56.75 | 16.1K | Off |
| 3 Apr 2026 | 15,810 KRW | -7.1% | 22,002 KRW | 22,094 KRW | -1.80 | -53.10 | 10.4K | Off |
| 27 Mar 2026 | 17,020 KRW | 1.9% | 22,260 KRW | 22,197 KRW | -1.71 | -50.32 | 9.8K | Off |
| 20 Mar 2026 | 16,700 KRW | 1.2% | 22,427 KRW | 22,288 KRW | -1.61 | -54.35 | 10.1K | Off |
| 13 Mar 2026 | 16,500 KRW | -0.5% | 22,632 KRW | 22,383 KRW | -1.57 | -52.74 | 14.7K | Off |